MyFinsight
Home
Blog
About
Net increase
(decrease) in cash and cash...
-$7,666K
(-1587.54%↓ Y/Y)
Accrued expenses
$8,306K
Change in fair value of
convertible notes
-$3,705K
Stock-based compensation
$2,760K
(206.90%↑ Y/Y)
Inventory
-$1,218K
Amortization of intangible
assets
$1,043K
Accretion of interest for
royalty obligations
$963K
Inventory write-off
$925K
Depreciation of property and
equipment
$278K
Amortization of debt discount
$237K
(-8.46%↓ Y/Y)
Operating lease
right-of-use assets
-$105K
Lease amortization
expense
$68K
Net cash used in
operating activities
-$7,664K
(-610.11%↓ Y/Y)
Net cash used in
investing activities
-$2K
Canceled cashflow
$19,608K
Net loss
-$23,417K
(-332.32%↓ Y/Y)
Purchases of property and
equipment
$2K
Accounts receivable
$2,782K
Prepaid expenses
$385K
(826.98%↑ Y/Y)
Accounts payable
-$338K
Deferred revenue
-$183K
Operating lease
liabilities
-$167K
Back
Back
Cash Flow
Pelthos Therapeutics Inc. (PTHS)
Pelthos Therapeutics Inc. (PTHS)
source: myfinsight.com